INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹376 Cr | ₹294 Cr | ₹278 Cr | ₹315 Cr | ₹215 Cr |
What is the latest Total Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹376 Cr |
| Mar2024 | ₹294 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹315 Cr |
| Mar2021 | ₹215 Cr |
How is Total Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹376 Cr | 28.05 | |
| Mar2024 | ₹294 Cr | 5.92 | |
| Mar2023 | ₹278 Cr | -12.02 | |
| Mar2022 | ₹315 Cr | 46.63 | |
| Mar2021 | ₹215 Cr | - | |
Compare Total Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,691.7 Cr | -5% | -6.5% | -37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -5% |
-6.5% |
-37.3% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses